We provide full-lifecycle, GMP-aligned turnkey biopharma facility construction services based in China, delivering integrated industrial solutions for global pharmaceutical and biotech clients. Covering greenfield new-build plants, brownfield renovation, capacity expansion and compliance upgrading projects, our multi-disciplinary turnkey scope integrates process engineering, architectural construction, HVAC environmental control, purified water system deployment and electrical automation engineering. Serving vaccines, monoclonal antibodies, recombinant proteins, cell and gene therapies, sterile formulations and veterinary biologic facilities, our one-stop construction model unifies design, fabrication, installation, system integration and qualification, enabling cost-effective, schedule-controlled and audit-ready biomanufacturing plant delivery for global clients.
Our China-based turnkey biopharma construction adopts core principles offull-discipline integrated delivery, standardized GMP construction management, modularized fabrication efficiency and risk-controlled project execution. We synchronize process layout logic with architectural spatial planning, tailor graded cleanroom envelope structures, and deploy precisely calibrated HVAC pressure cascade and aseptic airflow systems. Matching pharma-grade purified water generation, distribution and sanitization systems, together with stable power supply, grounding and automated control electrical systems, the entire facility achieves systematic compliance and operational consistency. Adopting prefabricated modular components and standardized construction workflows, we eliminate cross-discipline conflicts, reduce on-site construction cycles and ensure stable quality across all project phases.
All construction specifications, material standards, system integration rules and quality control procedures fully conform to global pharmaceutical benchmarks including FDA cGMP, EMA Annex 1, ICH Q-series, PIC/S and ISPE guidelines. The integrated facility monitoring and automation architecture complies with 21 CFR Part 11 data integrity requirements, supporting full-process parameter recording, electronic batch tracking and immutable audit trails. Every construction detail is strictly validated for contamination control, aseptic stability, cleanroom grading and utility reliability, ensuring complete inspection readiness for overseas regulatory audits and international product licensing.
We deliver end-to-end turnkey services including project feasibility study, conceptual and multi-disciplinary detailed design, cleanroom construction, utility system implementation, equipment integration, commissioning, performance verification and full IQ/OQ/PQ qualification documentation handover. As a China-based full-stack biopharma engineering provider, we integrate mature supply chain resources, standardized construction quality control and efficient project management mechanisms. Clients gain high-quality, cost-optimized and globally compliant biopharmaceutical manufacturing facilities with shorter lead times, lower CAPEX and sustainable operational stability for global market expansion.
